Cardiac risk of noncardiac surgery

AY Patel, KA Eagle, P Vaishnava - Journal of the American College of …, 2015 - jacc.org
Major perioperative cardiac events are estimated to complicate between 1.4% and 3.9% of
surgeries. Because most surgeries are elective, there is the opportunity to implement …

Species differences in platelet protease-activated receptors

SA Renna, SE McKenzie, JV Michael - International Journal of Molecular …, 2023 - mdpi.com
Protease-activated receptors (PARs) are a class of integral membrane proteins that are
cleaved by a variety of proteases, most notably thrombin, to reveal a tethered ligand and …

[HTML][HTML] Endovascular interventions for claudication do not meet minimum standards for the Society for Vascular Surgery efficacy guidelines

J Bath, PF Lawrence, D Neal, Y Zhao, JB Smith… - Journal of vascular …, 2021 - Elsevier
Objective Because the treatment of intermittent claudication (IC) is elective, good short-and
long-term outcomes are imperative. The objective of the present study was to examine the …

Consensus document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: long-term antiplatelet therapy in patients with coronary artery disease

MM Gulizia, F Colivicchi, MG Abrignani… - European Heart …, 2018 - academic.oup.com
Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the
cornerstone of pharmacologic management of patients with acute coronary syndrome (ACS) …

Platelets and coronary artery disease: Interactions with the blood vessel wall and cardiovascular devices

M Reinthaler, S Braune, A Lendlein, U Landmesser… - …, 2016 - pubs.aip.org
In view of the rare presence of studies concerning platelet function as risk factor in
atherosclerotic patients, processes underlying thromboembolic events are reviewed in this …

The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts

JY Moon, F Franchi, F Rollini… - Expert Review of …, 2018 - Taylor & Francis
Introduction: Despite the undeniable benefits on reducing ischemic adverse events,
antiplatelet regimens including dual antiplatelet therapy (DAPT) with aspirin and P2Y12 …

Benefit and risk of prolonged DAPT after coronary stenting in women: results from the DAPT Study

NC Berry, DJ Kereiakes, RW Yeh, PG Steg… - Circulation …, 2018 - Am Heart Assoc
Background: Women may derive differential benefit from prolonged DAPT (dual antiplatelet
therapy) after coronary stenting than men. We assessed whether the risks/benefits of …

Metalloproteolytic receptor shedding… platelets “acting their age”

RK Andrews, EE Gardiner - Platelets, 2016 - Taylor & Francis
Whilst significant effort has been focused on development of tools and approaches to
clinically modulate activation processes that consume platelets, the platelet receptors that …

The role of Sphingomyelin synthase 2 (SMS2) in platelet activation and its clinical significance

Y Guo, L Chang, G Zhang, Z Gao, H Lin, Y Zhang… - Thrombosis …, 2021 - Springer
Background Sphingomyelin (SM) is an essential component of biological lipid rafts, and it
plays an indispensable role in maintaining plasma membrane stability and in mediating …

Determinants of high on-treatment platelet reactivity and agreement between VerifyNow and Multiplate assays

D Danielak, A Komosa, A Tomczak… - … Journal of Clinical …, 2017 - Taylor & Francis
Dual antiplatelet therapy with clopidogrel is a regimen used before and after drug-eluting
stent (DES) implantation. Point-of-care platelet reactivity assays are easy-to-use methods to …